{
    "2018-03-30": [
        [
            {
                "time": "2018-05-02",
                "original_text": "摘中概股IPO回A首单 “独角兽”药明康德“狮子大张口”？",
                "features": {
                    "keywords": [
                        "IPO",
                        "独角兽",
                        "药明康德"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "2018年全球CRO公司TOP10排名，药明康德升至第9",
                "features": {
                    "keywords": [
                        "全球CRO",
                        "药明康德",
                        "排名"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "研发服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "众生药业：一类创新药物ZSP1601临床试验进展顺利",
                "features": {
                    "keywords": [
                        "众生药业",
                        "创新药物",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-20",
                "original_text": "寻找下一个药明康德",
                "features": {
                    "keywords": [
                        "药明康德",
                        "投资机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-05",
                "original_text": "证券研究院 | A股正上演“回家的诱惑” 机会与幻灭只在一瞬间",
                "features": {
                    "keywords": [
                        "A股",
                        "回家的诱惑",
                        "机会",
                        "幻灭"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "股市"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "生物制品行业周报:药明康德顺利过会募资57亿元",
                "features": {
                    "keywords": [
                        "生物制品",
                        "药明康德",
                        "过会",
                        "募资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}